Sumitomo Dainippon Pharma Co Ltd - Research and Development

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Research-and-Development" stands at 44.92 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 12/31/2011, the period currently displayed.

Sumitomo Dainippon Pharma Co Ltd's first quarter result of 8.18 Billion JPY for the item "Research and Development" represents a decrease of -37.72 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Sumitomo Dainippon Pharma Co Ltd's first quarter result of 8.18 Billion JPY for the item "Research and Development" represents a decrease of -37.71 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's first quarter result of 44.92 Billion JPY for the item "Research and Development" represents a decrease of -9.92 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -54.13 percent compared to the value the year prior.
The 1 year change in percent is -54.13.
The 3 year change in percent is -53.65.
The 5 year change in percent is -62.82.
The 10 year change in percent is -41.05.

The Serie's long term average value is 89.00 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 49.53 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 06/30/2023, to it's latest available value, on 06/30/2025, is -66.80%.